Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 26;24(1):e27349.
doi: 10.2196/27349.

A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation Trial

Alessandro Passardi  1 , Flavia Foca  2 , Orazio Caffo  3 , Carlo Alberto Tondini  4 , Alberto Zambelli  4 , Roberto Vespignani  5 , Giulia Bartolini  1 , Francesco Giulio Sullo  1 , Daniele Andreis  2 , Marco Dianti  6 , Claudio Eccher  6 , Enrico Maria Piras  6 , Stefano Forti  6
Affiliations

A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation Trial

Alessandro Passardi et al. J Med Internet Res. .

Abstract

Background: A platform designed to support the home management of oral anticancer treatments and provide a secure web-based patient-health care professional communication modality, ONCO-TreC, was tested in 3 cancer centers in Italy.

Objective: The overall aims of the trial are to customize the platform; assess the system's ability to facilitate the shared management of oral anticancer therapies by patients and health professionals; and evaluate system usability and acceptability by patients, caregivers, and health care professionals.

Methods: Patients aged ≥18 years who were candidates for oral anticancer treatment as monotherapy with an Eastern Cooperative Oncology Group performance status score of 0 to 1 and a sufficient level of familiarity with mobile devices were eligible. ONCO-TreC consisted of a mobile app for patients and a web-based dashboard for health care professionals. Adherence to treatment (pill count) and toxicities reported by patients through the app were compared with those reported by physicians in medical records. Usability and acceptability were evaluated using questionnaires.

Results: A total of 40 patients were enrolled, 38 (95%) of whom were evaluable for adherence to treatment. The ability of the system to measure adherence to treatment was high, with a concordance of 97.3% (95% CI 86.1%-99.9%) between the investigator and system pill count. Only 60% (3/5) of grade 3, 54% (13/24) of grade 2, and 19% (7/36) of grade 1 adverse events reported by physicians in the case report forms were also reported in the app directly by patients. In total, 94% (33/35) of patients had ≥1 app launch each week, and the median number of daily accesses per patient was 2. Approximately 71% (27/38) and 68% (26/38) of patients used the app for messages and vital sign entering, respectively, at least once during the study period.

Conclusions: ONCO-TreC is an important tool for measuring and monitoring adherence to oral anticancer drugs. System usability and acceptability were very high, whereas its reliability in registering toxicity could be improved.

Trial registration: ClinicalTrials.gov NCT02921724; https://www.clinicaltrials.gov/ct2/show/NCT02921724.

Keywords: ONCO-TreC; adherence; electronic diary; mHealth; oral anticancer drug.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

References

    1. O'Neill VJ, Twelves CJ. Oral cancer treatment: developments in chemotherapy and beyond. Br J Cancer. 2002 Oct 21;87(9):933–7. doi: 10.1038/sj.bjc.6600591. http://europepmc.org/abstract/MED/12434279 - DOI - PMC - PubMed
    1. Findlay M, von Minckwitz G, Wardley A. Effective oral chemotherapy for breast cancer: pillars of strength. Ann Oncol. 2008 Feb;19(2):212–22. doi: 10.1093/annonc/mdm285. https://linkinghub.elsevier.com/retrieve/pii/S0923-7534(19)41320-3 S0923-7534(19)41320-3 - DOI - PubMed
    1. Borner M, Scheithauer W, Twelves C, Maroun J, Wilke H. Answering patients' needs: oral alternatives to intravenous therapy. Oncologist. 2001;6 Suppl 4:12–6. doi: 10.1634/theoncologist.6-suppl_4-12. https://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pu... - DOI - PubMed
    1. Weingart SN, Brown E, Bach PB, Eng K, Johnson SA, Kuzel TM, Langbaum TS, Leedy RD, Muller RJ, Newcomer LN, O'Brien S, Reinke D, Rubino M, Saltz L, Walters RS. NCCN Task Force Report: oral chemotherapy. J Natl Compr Canc Netw. 2008 Mar;6 Suppl 3:S1–14. - PubMed
    1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 Aug 04;353(5):487–97. doi: 10.1056/NEJMra050100.353/5/487 - DOI - PubMed

Publication types

Associated data